(Q48468772)

11 February 2018

title

Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches? (English)

1 reference

11 February 2018

author name string

Yi-Yang Yvonne Li

series ordinal

1

1 reference

11 February 2018

H Daniel Perez

series ordinal

2

1 reference

11 February 2018

Thomas M Zollner

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

11 February 2018

Expert Opinion on Therapeutic Targets

published in

1 reference

11 February 2018

volume

10

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

489-499

1 reference

11 February 2018

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Rodent models of lymphocyte migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

21 January 2018

Anti-adhesion therapies

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

The human polyomavirus, JCV, uses serotonin receptors to infect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Interaction of the human polyomavirus, JCV, with human B-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

JAM2 interacts with alpha4beta1. Facilitation by JAM3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Integrin-mediated long-term B cell retention in the splenic marginal zone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Transplanted bone marrow generates new neurons in human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Liver from bone marrow in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Adult stem cells for tissue repair - a new therapeutic concept?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

Progressive multifocal leukoencephalopathy in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.489

10.1517/14728222.10.4.489

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018